T. Rowe Price Associates’s Oscar Health OSCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22M | Sell |
1,913,902
-846,863
| -31% | -$11.9M | ﹤0.01% | 1014 |
|
|
2025
Q4 | $39.7M | Sell |
2,760,765
-238,853
| -8% | -$4.13M | ﹤0.01% | 876 |
|
|
2025
Q3 | $56.8M | Buy |
2,999,618
+2,319,254
| +341% | +$38.2M | 0.01% | 766 |
|
|
2025
Q2 | $14.6M | Sell |
680,364
-2,644,932
| -80% | -$39.3M | ﹤0.01% | 1037 |
|
|
2025
Q1 | $43.6M | Sell |
3,325,296
-1,419,606
| -30% | -$21.1M | 0.01% | 761 |
|
|
2024
Q4 | $63.8M | Sell |
4,744,902
-643,159
| -12% | -$10.4M | 0.01% | 677 |
|
|
2024
Q3 | $114M | Buy |
5,388,061
+431,626
| +9% | +$7.77M | 0.01% | 539 |
|
|
2024
Q2 | $78.4M | Buy |
4,956,435
+978,283
| +25% | +$18M | 0.01% | 600 |
|
|
2024
Q1 | $59.2M | Buy |
3,978,152
+2,409,160
| +154% | +$33M | 0.01% | 681 |
|
|
2023
Q4 | $14.4M | Buy |
1,568,992
+704,913
| +82% | +$4.86M | ﹤0.01% | 1027 |
|
|
2023
Q3 | $4.81M | Buy |
864,079
+813,456
| +1,607% | +$5.69M | ﹤0.01% | 1190 |
|
|
2023
Q2 | $409K | Buy |
50,623
+5,601
| +12% | +$41.3K | ﹤0.01% | 2225 |
|
|
2023
Q1 | $295K | Buy |
45,022
+1,651
| +4% | +$6.74K | ﹤0.01% | 2352 |
|
|
2022
Q4 | $107K | Sell |
43,371
-90,735
| -68% | -$284K | ﹤0.01% | 2705 |
|
|
2022
Q3 | $670K | Sell |
134,106
-288,226
| -68% | -$1.68M | ﹤0.01% | 1976 |
|
|
2022
Q2 | $1.79M | Buy |
422,332
+292,016
| +224% | +$1.86M | ﹤0.01% | 1650 |
|
|
2022
Q1 | $1.3M | Buy |
130,316
+2,000
| +2% | +$14.9K | ﹤0.01% | 1871 |
|
|
2021
Q4 | $1.01M | Sell |
128,316
-24,828
| -16% | -$312K | ﹤0.01% | 2039 |
|
|
2021
Q3 | $2.66M | Sell |
153,144
-234,887
| -61% | -$3.98M | ﹤0.01% | 1629 |
|
|
2021
Q2 | $8.34M | Sell |
388,031
-113,632
| -23% | -$2.72M | ﹤0.01% | 1437 |
|
|
2021
Q1 | $13.5M | Buy |
+501,663
| New | +$15.7M | ﹤0.01% | 1345 |
|
Other funds holding OSCR
VCM
VPM
TCMNY
BC
